-
Je něco špatně v tomto záznamu ?
RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays
M. Port, JF. Barquinero, D. Endesfelder, J. Moquet, U. Oestreicher, G. Terzoudi, F. Trompier, A. Vral, Y. Abe, L. Ainsbury, L. Alkebsi, SA. Amundson, C. Badie, A. Baeyens, AS. Balajee, K. Balázs, S. Barnard, C. Bassinet, LA. Beaton-Green, C....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
U19 AI067773
NIAID NIH HHS - United States
PubMed
37310880
DOI
10.1667/rade-22-00207.1
Knihovny.cz E-zdroje
- MeSH
- biotest * MeSH
- cytokineze MeSH
- elektronová paramagnetická rezonance MeSH
- odběr vzorku krve * MeSH
- retrospektivní studie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Tools for radiation exposure reconstruction are required to support the medical management of radiation victims in radiological or nuclear incidents. Different biological and physical dosimetry assays can be used for various exposure scenarios to estimate the dose of ionizing radiation a person has absorbed. Regular validation of the techniques through inter-laboratory comparisons (ILC) is essential to guarantee high quality results. In the current RENEB inter-laboratory comparison, the performance quality of established cytogenetic assays [dicentric chromosome assay (DCA), cytokinesis-block micronucleus assay (CBMN), stable chromosomal translocation assay (FISH) and premature chromosome condensation assay (PCC)] was tested in comparison to molecular biological assays [gamma-H2AX foci (gH2AX), gene expression (GE)] and physical dosimetry-based assays [electron paramagnetic resonance (EPR), optically or thermally stimulated luminescence (LUM)]. Three blinded coded samples (e.g., blood, enamel or mobiles) were exposed to 0, 1.2 or 3.5 Gy X-ray reference doses (240 kVp, 1 Gy/min). These doses roughly correspond to clinically relevant groups of unexposed to low exposed (0-1 Gy), moderately exposed (1-2 Gy, no severe acute health effects expected) and highly exposed individuals (>2 Gy, requiring early intensive medical care). In the frame of the current RENEB inter-laboratory comparison, samples were sent to 86 specialized teams in 46 organizations from 27 nations for dose estimation and identification of three clinically relevant groups. The time for sending early crude reports and more precise reports was documented for each laboratory and assay where possible. The quality of dose estimates was analyzed with three different levels of granularity, 1. by calculating the frequency of correctly reported clinically relevant dose categories, 2. by determining the number of dose estimates within the uncertainty intervals recommended for triage dosimetry (±0.5 Gy or ±1.0 Gy for doses <2.5 Gy or >2.5 Gy), and 3. by calculating the absolute difference (AD) of estimated doses relative to the reference doses. In total, 554 dose estimates were submitted within the 6-week period given before the exercise was closed. For samples processed with the highest priority, earliest dose estimates/categories were reported within 5-10 h of receipt for GE, gH2AX, LUM, EPR, 2-3 days for DCA, CBMN and within 6-7 days for the FISH assay. For the unirradiated control sample, the categorization in the correct clinically relevant group (0-1 Gy) as well as the allocation to the triage uncertainty interval was, with the exception of a few outliers, successfully performed for all assays. For the 3.5 Gy sample the percentage of correct classifications to the clinically relevant group (≥2 Gy) was between 89-100% for all assays, with the exception of gH2AX. For the 1.2 Gy sample, an exact allocation to the clinically relevant group was more difficult and 0-50% or 0-48% of the estimates were wrongly classified into the lowest or highest dose categories, respectively. For the irradiated samples, the correct allocation to the triage uncertainty intervals varied considerably between assays for the 1.2 Gy (29-76%) and 3.5 Gy (17-100%) samples. While a systematic shift towards higher doses was observed for the cytogenetic-based assays, extreme outliers exceeding the reference doses 2-6 fold were observed for EPR, FISH and GE assays. These outliers were related to a particular material examined (tooth enamel for EPR assay, reported as kerma in enamel, but when converted into the proper quantity, i.e. to kerma in air, expected dose estimates could be recalculated in most cases), the level of experience of the teams (FISH) and methodological uncertainties (GE). This was the first RENEB ILC where everything, from blood sampling to irradiation and shipment of the samples, was organized and realized at the same institution, for several biological and physical retrospective dosimetry assays. Almost all assays appeared comparably applicable for the identification of unexposed and highly exposed individuals and the allocation of medical relevant groups, with the latter requiring medical support for the acute radiation scenario simulated in this exercise. However, extreme outliers or a systematic shift of dose estimates have been observed for some assays. Possible reasons will be discussed in the assay specific papers of this special issue. In summary, this ILC clearly demonstrates the need to conduct regular exercises to identify research needs, but also to identify technical problems and to optimize the design of future ILCs.
Belgian Nuclear Research Center SCK CEN Mol Belgium
Bundesamt für Strahlenschutz Oberschleißheim Germany
Bundeswehr Institute of Radiobiology Munich Germany
CEA Saclay Gif sur Yvette Cedex France
Columbia University Irving Medical Center Center for Radiological Research New York New York
Dalat Nuclear Research Institute Radiation Technlogy and Biotechnology Center Dalat City Vietnam
Department of Radiation Biology and Protection Nagasaki University Japan
Department of Safety and Radiation Protection Forschungszentrum Jülich Jülich Germany
Genevolution Porcheville France
Ghent University Radiobiology Research Unit Gent Belgium
Hospital General Universitario Gregorio Marañón Laboratorio de dosimetría biológica Madrid Spain
Institut de Radioprotection et de Surete Nucleaire Fontenay aux Roses France
Institut de Recherche Biomédicale des Armées Bretigny Sur Orge France
Institute of Nuclear Chemistry and Technology Warsaw Poland
Institute of Nuclear Physics Polish Academy of Sciences Krakow Poland
Institute of Radiation Emergency Medicine Hirosaki University Hirosaki Japan
Instituto Superior Técnico Campus Tecnológico e Nuclear Lisbon Portugal
Italian National Agency for New Technologies Energy and Sustainable Economic Development Rome Italy
Laboratori Nazionali di Legnaro Istituto Nazionale di Fisica Nucleare Legnaro Italy
Medical University of Gdansk Department of Physics and Biophysics Gdansk Poland
National Centre of Radiobiology and Radiation Protection Sofia Bulgaria
National Institute of Public Health Radiation Hygiene Laboratory Bucharest Romania
Naval Dosimetry Center Bethesda Maryland
Paris Lodron University of Salzburg Department of Environment and Biodiversity 5020 Salzburg Austria
Radiation Dosimetry Laboratory Oklahoma State University Stillwater Oklahoma
Radiation Protection Centre Vilnius Lithuania
Ruðer Boškovic Institute Division of Physical Chemistry Zagreb Croatia
Serbian Institute of Occupational Health Belgrade Serbia
Servicio de Protección Radiológica Laboratorio de Dosimetría Biológica Valencia Spain
Stockholm University Stockholm Sweden
Universidad de Sevilla Departamento de Biología Celular Sevilla Spain
Università Degli Studi di Palermo Dipartimento di Fisica e Chimica Emilio Segrè Palermo Italy
Universitat Autònoma de Barcelona Barcelona Spain
University of Arizona Center for Applied Nanobioscience and Medicine Phoenix Arizona
University of Defense Faculty of Military Health Sciences Hradec Králové Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011128
- 003
- CZ-PrNML
- 005
- 20230801132825.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1667/RADE-22-00207.1 $2 doi
- 035 __
- $a (PubMed)37310880
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Port, M $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 245 10
- $a RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays / $c M. Port, JF. Barquinero, D. Endesfelder, J. Moquet, U. Oestreicher, G. Terzoudi, F. Trompier, A. Vral, Y. Abe, L. Ainsbury, L. Alkebsi, SA. Amundson, C. Badie, A. Baeyens, AS. Balajee, K. Balázs, S. Barnard, C. Bassinet, LA. Beaton-Green, C. Beinke, L. Bobyk, P. Brochard, K. Brzoska, M. Bucher, B. Ciesielski, C. Cuceu, M. Discher, MC. D Oca, I. Domínguez, S. Doucha-Senf, A. Dumitrescu, PN. Duy, F. Finot, G. Garty, SA. Ghandhi, E. Gregoire, VST. Goh, I. Güçlü, L. Hadjiiska, R. Hargitai, R. Hristova, K. Ishii, E. Kis, M. Juniewicz, R. Kriehuber, J. Lacombe, Y. Lee, M. Lopez Riego, K. Lumniczky, TT. Mai, N. Maltar-Strmečki, M. Marrale, JS. Martinez, A. Marciniak, N. Maznyk, SWS. McKeever, PK. Meher, M. Milanova, T. Miura, O. Monteiro Gil, A. Montoro, M. Moreno Domene, A. Mrozik, R. Nakayama, G. O'Brien, D. Oskamp, P. Ostheim, J. Pajic, N. Pastor, C. Patrono, M. Pujol-Canadell, MJ. Prieto Rodriguez, M. Repin, A. Romanyukha, U. Rößler, L. Sabatier, A. Sakai, H. Scherthan, S. Schüle, KM. Seong, O. Sevriukova, S. Sholom, S. Sommer, Y. Suto, T. Sypko, T. Szatmári, M. Takahashi-Sugai, K. Takebayashi, A. Testa, I. Testard, A. Tichy, S. Triantopoulou, N. Tsuyama, M. Unverricht-Yeboah, M. Valente, O. Van Hoey, RC. Wilkins, A. Wojcik, M. Wojewodzka, L. Younghyun, D. Zafiropoulos, M. Abend
- 520 9_
- $a Tools for radiation exposure reconstruction are required to support the medical management of radiation victims in radiological or nuclear incidents. Different biological and physical dosimetry assays can be used for various exposure scenarios to estimate the dose of ionizing radiation a person has absorbed. Regular validation of the techniques through inter-laboratory comparisons (ILC) is essential to guarantee high quality results. In the current RENEB inter-laboratory comparison, the performance quality of established cytogenetic assays [dicentric chromosome assay (DCA), cytokinesis-block micronucleus assay (CBMN), stable chromosomal translocation assay (FISH) and premature chromosome condensation assay (PCC)] was tested in comparison to molecular biological assays [gamma-H2AX foci (gH2AX), gene expression (GE)] and physical dosimetry-based assays [electron paramagnetic resonance (EPR), optically or thermally stimulated luminescence (LUM)]. Three blinded coded samples (e.g., blood, enamel or mobiles) were exposed to 0, 1.2 or 3.5 Gy X-ray reference doses (240 kVp, 1 Gy/min). These doses roughly correspond to clinically relevant groups of unexposed to low exposed (0-1 Gy), moderately exposed (1-2 Gy, no severe acute health effects expected) and highly exposed individuals (>2 Gy, requiring early intensive medical care). In the frame of the current RENEB inter-laboratory comparison, samples were sent to 86 specialized teams in 46 organizations from 27 nations for dose estimation and identification of three clinically relevant groups. The time for sending early crude reports and more precise reports was documented for each laboratory and assay where possible. The quality of dose estimates was analyzed with three different levels of granularity, 1. by calculating the frequency of correctly reported clinically relevant dose categories, 2. by determining the number of dose estimates within the uncertainty intervals recommended for triage dosimetry (±0.5 Gy or ±1.0 Gy for doses <2.5 Gy or >2.5 Gy), and 3. by calculating the absolute difference (AD) of estimated doses relative to the reference doses. In total, 554 dose estimates were submitted within the 6-week period given before the exercise was closed. For samples processed with the highest priority, earliest dose estimates/categories were reported within 5-10 h of receipt for GE, gH2AX, LUM, EPR, 2-3 days for DCA, CBMN and within 6-7 days for the FISH assay. For the unirradiated control sample, the categorization in the correct clinically relevant group (0-1 Gy) as well as the allocation to the triage uncertainty interval was, with the exception of a few outliers, successfully performed for all assays. For the 3.5 Gy sample the percentage of correct classifications to the clinically relevant group (≥2 Gy) was between 89-100% for all assays, with the exception of gH2AX. For the 1.2 Gy sample, an exact allocation to the clinically relevant group was more difficult and 0-50% or 0-48% of the estimates were wrongly classified into the lowest or highest dose categories, respectively. For the irradiated samples, the correct allocation to the triage uncertainty intervals varied considerably between assays for the 1.2 Gy (29-76%) and 3.5 Gy (17-100%) samples. While a systematic shift towards higher doses was observed for the cytogenetic-based assays, extreme outliers exceeding the reference doses 2-6 fold were observed for EPR, FISH and GE assays. These outliers were related to a particular material examined (tooth enamel for EPR assay, reported as kerma in enamel, but when converted into the proper quantity, i.e. to kerma in air, expected dose estimates could be recalculated in most cases), the level of experience of the teams (FISH) and methodological uncertainties (GE). This was the first RENEB ILC where everything, from blood sampling to irradiation and shipment of the samples, was organized and realized at the same institution, for several biological and physical retrospective dosimetry assays. Almost all assays appeared comparably applicable for the identification of unexposed and highly exposed individuals and the allocation of medical relevant groups, with the latter requiring medical support for the acute radiation scenario simulated in this exercise. However, extreme outliers or a systematic shift of dose estimates have been observed for some assays. Possible reasons will be discussed in the assay specific papers of this special issue. In summary, this ILC clearly demonstrates the need to conduct regular exercises to identify research needs, but also to identify technical problems and to optimize the design of future ILCs.
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a biotest $7 D001681
- 650 12
- $a odběr vzorku krve $7 D001800
- 650 _2
- $a cytokineze $7 D048749
- 650 _2
- $a elektronová paramagnetická rezonance $7 D004578
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Barquinero, J-F $u Universitat Autònoma de Barcelona, Barcelona, Spain
- 700 1_
- $a Endesfelder, D $u Bundesamt für Strahlenschutz, Oberschleißheim, Germany
- 700 1_
- $a Moquet, J $u UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
- 700 1_
- $a Oestreicher, U $u Bundesamt für Strahlenschutz, Oberschleißheim, Germany
- 700 1_
- $a Terzoudi, G $u National Centre for Scientific Research "Demokritos", Health Physics, Radiobiology & Cytogenetics Laboratory, Agia Paraskevi, Greece
- 700 1_
- $a Trompier, F $u Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
- 700 1_
- $a Vral, A $u Ghent University, Radiobiology Research Unit, Gent, Belgium
- 700 1_
- $a Abe, Y $u Department of Radiation Biology and Protection, Nagasaki University, Japan
- 700 1_
- $a Ainsbury, L $u UK Health Security Agency and Office for Health Improvement and Disparities, Cytogenetics and Pathology Group, Oxfordshire, England
- 700 1_
- $a Alkebsi, L $u Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
- 700 1_
- $a Amundson, S A $u Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
- 700 1_
- $a Badie, C $u UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
- 700 1_
- $a Baeyens, A $u Ghent University, Radiobiology Research Unit, Gent, Belgium
- 700 1_
- $a Balajee, A S $u Cytogenetic Biodosimetry Laboratory, Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee
- 700 1_
- $a Balázs, K $u Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
- 700 1_
- $a Barnard, S $u UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
- 700 1_
- $a Bassinet, C $u Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
- 700 1_
- $a Beaton-Green, L A $u Health Canada, Ottawa, Canada
- 700 1_
- $a Beinke, C $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 700 1_
- $a Bobyk, L $u Institut de Recherche Biomédicale des Armées (IRBA), Bretigny Sur Orge, France
- 700 1_
- $a Brochard, P $u CEA-Saclay, Gif-sur-Yvette Cedex, France
- 700 1_
- $a Brzoska, K $u Institute of Nuclear Chemistry and Technology, Warsaw, Poland
- 700 1_
- $a Bucher, M $u Bundesamt für Strahlenschutz, Oberschleißheim, Germany
- 700 1_
- $a Ciesielski, B $u Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
- 700 1_
- $a Cuceu, C $u Genevolution, Porcheville, France
- 700 1_
- $a Discher, M $u Paris-Lodron-University of Salzburg, Department of Environment and Biodiversity, 5020 Salzburg, Austria
- 700 1_
- $a D Oca, M C $u Università Degli Studi di Palermo, Dipartimento di Fisica e Chimica "Emilio Segrè," Palermo, Italy
- 700 1_
- $a Domínguez, I $u Universidad de Sevilla, Departamento de Biología Celular, Sevilla, Spain
- 700 1_
- $a Doucha-Senf, S $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 700 1_
- $a Dumitrescu, A $u National Institute of Public Health, Radiation Hygiene Laboratory, Bucharest, Romania
- 700 1_
- $a Duy, P N $u Dalat Nuclear Research Institute, Radiation Technlogy & Biotechnology Center, Dalat City, Vietnam
- 700 1_
- $a Finot, F $u Genevolution, Porcheville, France
- 700 1_
- $a Garty, G $u Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
- 700 1_
- $a Ghandhi, S A $u Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
- 700 1_
- $a Gregoire, E $u Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
- 700 1_
- $a Goh, V S T $u Department of Radiobiology, Singapore Nuclear Research and Safety Initiative (SNRSI), National University of Singapore, Singapore
- 700 1_
- $a Güçlü, I $u TENMAK, Nuclear Energy Research Institute,Technology Development and Nuclear Research Department, Türkey
- 700 1_
- $a Hadjiiska, L $u National Centre of Radiobiology and Radiation Protection, Sofia, Bulgaria
- 700 1_
- $a Hargitai, R $u Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
- 700 1_
- $a Hristova, R $u National Centre of Radiobiology and Radiation Protection, Sofia, Bulgaria
- 700 1_
- $a Ishii, K $u Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
- 700 1_
- $a Kis, E $u Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
- 700 1_
- $a Juniewicz, M $u Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
- 700 1_
- $a Kriehuber, R $u Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
- 700 1_
- $a Lacombe, J $u University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
- 700 1_
- $a Lee, Y $u Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
- 700 1_
- $a Lopez Riego, M $u Stockholm University, Stockholm, Sweden
- 700 1_
- $a Lumniczky, K $u Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
- 700 1_
- $a Mai, T T $u Dalat Nuclear Research Institute, Radiation Technlogy & Biotechnology Center, Dalat City, Vietnam
- 700 1_
- $a Maltar-Strmečki, N $u Ruðer Boškovic Institute, Division of Physical Chemistry, Zagreb, Croatia
- 700 1_
- $a Marrale, M $u Università Degli Studi di Palermo, Dipartimento di Fisica e Chimica "Emilio Segrè," Palermo, Italy
- 700 1_
- $a Martinez, J S $u Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
- 700 1_
- $a Marciniak, A $u Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
- 700 1_
- $a Maznyk, N $u Radiation Cytogenetics Laboratory, S.P. Grigoriev Institute for Medical Radiology and Oncology of Ukrainian National Academy of Medical Science, Kharkiv, Ukraine
- 700 1_
- $a McKeever, S W S $u Radiation Dosimetry Laboratory, Oklahoma State University, Stillwater, Oklahoma
- 700 1_
- $a Meher, P K $u Stockholm University, Stockholm, Sweden
- 700 1_
- $a Milanova, M $u University of Defense, Faculty of Military Health Sciences, Hradec Králové, Czech Republic
- 700 1_
- $a Miura, T $u Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
- 700 1_
- $a Monteiro Gil, O $u Instituto Superior Técnico/Campus Tecnológico e Nuclear, Lisbon, Portugal
- 700 1_
- $a Montoro, A $u Servicio de Protección Radiológica. Laboratorio de Dosimetría Biológica, Valencia, Spain
- 700 1_
- $a Moreno Domene, M $u Hospital General Universitario Gregorio Marañón, Laboratorio de dosimetría biológica, Madrid, Spain
- 700 1_
- $a Mrozik, A $u Institute of Nuclear Physics, Polish Academy of Sciences, Krakow, Poland
- 700 1_
- $a Nakayama, R $u Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
- 700 1_
- $a O'Brien, G $u UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
- 700 1_
- $a Oskamp, D $u Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
- 700 1_
- $a Ostheim, P $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 700 1_
- $a Pajic, J $u Serbian Institute of Occupational Health, Belgrade, Serbia
- 700 1_
- $a Pastor, N $u Universidad de Sevilla, Departamento de Biología Celular, Sevilla, Spain
- 700 1_
- $a Patrono, C $u Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Rome, Italy
- 700 1_
- $a Pujol-Canadell, M $u Universitat Autònoma de Barcelona, Barcelona, Spain
- 700 1_
- $a Prieto Rodriguez, M J $u Hospital General Universitario Gregorio Marañón, Laboratorio de dosimetría biológica, Madrid, Spain
- 700 1_
- $a Repin, M $u Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
- 700 1_
- $a Romanyukha, A $u Naval Dosimetry Center, Bethesda, Maryland
- 700 1_
- $a Rößler, U $u Bundesamt für Strahlenschutz, Oberschleißheim, Germany
- 700 1_
- $a Sabatier, L $u CEA-Saclay, Gif-sur-Yvette Cedex, France
- 700 1_
- $a Sakai, A $u Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
- 700 1_
- $a Scherthan, H $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 700 1_
- $a Schüle, S $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 700 1_
- $a Seong, K M $u Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
- 700 1_
- $a Sevriukova, O $u Radiation Protection Centre, Vilnius, Lithuania
- 700 1_
- $a Sholom, S $u Radiation Dosimetry Laboratory, Oklahoma State University, Stillwater, Oklahoma
- 700 1_
- $a Sommer, S $u Institute of Nuclear Chemistry and Technology, Warsaw, Poland
- 700 1_
- $a Suto, Y $u Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
- 700 1_
- $a Sypko, T $u Radiation Cytogenetics Laboratory, S.P. Grigoriev Institute for Medical Radiology and Oncology of Ukrainian National Academy of Medical Science, Kharkiv, Ukraine
- 700 1_
- $a Szatmári, T $u Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
- 700 1_
- $a Takahashi-Sugai, M $u Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
- 700 1_
- $a Takebayashi, K $u Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
- 700 1_
- $a Testa, A $u Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Rome, Italy
- 700 1_
- $a Testard, I $u CEA-Saclay, Gif-sur-Yvette Cedex, France
- 700 1_
- $a Tichy, A $u University of Defense, Faculty of Military Health Sciences, Hradec Králové, Czech Republic
- 700 1_
- $a Triantopoulou, S $u National Centre for Scientific Research "Demokritos", Health Physics, Radiobiology & Cytogenetics Laboratory, Agia Paraskevi, Greece
- 700 1_
- $a Tsuyama, N $u Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
- 700 1_
- $a Unverricht-Yeboah, M $u Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
- 700 1_
- $a Valente, M $u CEA-Saclay, Gif-sur-Yvette Cedex, France
- 700 1_
- $a Van Hoey, O $u Belgian Nuclear Research Center SCK CEN, Mol, Belgium
- 700 1_
- $a Wilkins, R C $u Health Canada, Ottawa, Canada
- 700 1_
- $a Wojcik, A $u Stockholm University, Stockholm, Sweden
- 700 1_
- $a Wojewodzka, M $u Institute of Nuclear Chemistry and Technology, Warsaw, Poland
- 700 1_
- $a Younghyun, Lee $u Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
- 700 1_
- $a Zafiropoulos, D $u Laboratori Nazionali di Legnaro - Istituto Nazionale di Fisica Nucleare, Legnaro, Italy
- 700 1_
- $a Abend, M $u Bundeswehr Institute of Radiobiology, Munich, Germany
- 773 0_
- $w MED00010511 $t Radiation research $x 1938-5404 $g Roč. 199, č. 6 (2023), s. 535-555
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37310880 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132822 $b ABA008
- 999 __
- $a ok $b bmc $g 1963494 $s 1197393
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 199 $c 6 $d 535-555 $e 2023Jun01 $i 1938-5404 $m Radiation research $n Radiat Res $x MED00010511
- GRA __
- $a U19 AI067773 $p NIAID NIH HHS $2 United States
- LZP __
- $a Pubmed-20230718
